TrimmTrack
Sign in

Johnson & Johnson vs Pfizer: financial comparison

Compare Johnson & Johnson and Pfizer side by side: valuation, margins, growth, cash and dividends, with the quarterly history of both. Yahoo Finance data, free and no sign-up.

JNJ

Johnson & Johnson

JNJ

267.73 USD

See the Johnson & Johnson breakdown →
PFE

Pfizer

PFE

28.11 USD

See the Pfizer breakdown →

Johnson & Johnson vs Pfizer: key metrics

Johnson & JohnsonUSDPfizerUSD
Valuation
Market cap645.19 B USD160.20 B USD
P/E (TTM)31.0936.50
Forward P/E22.069.70
Price / Sales6.592.51
EV / EBITDA19.418.32
Price / Book7.591.88
Margins & growth
Profit margin+21.48%+6.8%
Operating margin+29.19%+27.88%
Quarterly revenue (YoY)+6.6%—
Quarterly earnings (YoY)-0.05%—
Cash flow
FCF yield+2.62%+7.79%
Stock-based compensation——
Balance
Cash20.76 B USD11.70 B USD
Debt49.04 B USD63.48 B USD
Net position-28.28 B USD-51.78 B USD
Dividend
Dividend yield+1.99%+6.16%
Payout ratio+60.79%+226.32%

Each column shows figures in that company's reporting currency (shown in the header); they are not converted. Ratios and percentages are currency-independent.

Price, rebased to 100

Johnson & Johnson163Pfizer64
5010015020212026

P/E (TTM)

Johnson & Johnson31.0×Pfizer37.0×
25507520212026

Both curves start at 100 on the same day, so this compares returns rather than prices. Each week's P/E is the price divided by the earnings per share already reported by that date; loss-making weeks are not drawn.

What analysts expect

Consensus revenue and earnings per share for the periods not yet reported.

Revenue forecast · Johnson & Johnson

ReportedEstimate
010B20BQ3 25: 23.99 B USDQ3 25Q4 25: 24.56 B USDQ4 25Q1 26: 24.06 B USDQ1 26Q2 26: 25.31 B USDQ2 26Q3 26 · Estimate: 25.29 B USD (25.04 B USD – 25.70 B USD)Q3 26Q4 26 · Estimate: 26.51 B USD (26.31 B USD – 26.78 B USD)Q4 26USD

Consensus of 6 analysts for Q3 26 · +5.41% year on year

Revenue forecast · Pfizer

ReportedEstimate
05B10B15BQ3 25: 16.65 B USDQ3 25Q4 25: 17.56 B USDQ4 25Q1 26: 14.45 B USDQ1 26Q2 26: 15.03 B USDQ2 26Q3 26 · Estimate: 15.95 B USD (14.99 B USD – 16.85 B USD)Q3 26Q4 26 · Estimate: 16.87 B USD (16.12 B USD – 18.11 B USD)Q4 26USD

Consensus of 16 analysts for Q3 26 · -4.23% year on year

EPS forecast · Johnson & Johnson

ReportedEstimate
0123Q3 25: 2.80 · expected 2.76 (+1.49%)Q3 25Q4 25: 2.46 · expected 2.46 (-0.11%)Q4 25Q1 26: 2.70 · expected 2.68 (+0.85%)Q1 26Q2 26: 2.90 · expected 2.85 (+1.58%)Q2 26Q3 26 · Estimate: 2.45 (2.31 – 2.66)Q3 26Q4 26 · Estimate: 2.97 (2.74 – 3.13)Q4 26

Consensus of 6 analysts for Q3 26 · -12.38% year on year · adjusted earnings

EPS forecast · Pfizer

ReportedEstimate
00.250.50.75Q3 25: 0.87 · expected 0.63 (+37.43%)Q3 25Q4 25: 0.66 · expected 0.57 (+16.18%)Q4 25Q1 26: 0.75 · expected 0.72 (+3.93%)Q1 26Q2 26: 0.77 · expected 0.68 (+12.87%)Q2 26Q3 26 · Estimate: 0.76 (0.59 – 0.94)Q3 26Q4 26 · Estimate: 0.71 (0.60 – 0.81)Q4 26

Consensus of 18 analysts for Q3 26 · -12.77% year on year · adjusted earnings

Analyst consensus from Yahoo Finance. The dashed bar is the average and the whisker runs from the lowest analyst to the highest. On periods already reported, the green or red line marks what had been expected: below the bar means the company beat it. EPS is measured on an adjusted basis, which is what analysts forecast against and is not the accounting profit in the statements.

Compared over time

Revenue

Johnson & JohnsonPfizer
010B20BQ3 22 · Johnson & Johnson: 20.22 B USDQ3 22 · Pfizer: 27.74 B USDQ3 22Q4 22 · Johnson & Johnson: 20.00 B USDQ4 22 · Pfizer: 15.75 B USDQ1 23 · Johnson & Johnson: 19.94 B USDQ2 23 · Johnson & Johnson: 20.89 B USDQ2 23 · Pfizer: 18.49 B USDQ2 23Q3 23 · Johnson & Johnson: 21.52 B USDQ3 23 · Pfizer: 13.01 B USDQ4 23 · Johnson & Johnson: 21.40 B USDQ4 23 · Pfizer: 5.93 B USDQ1 24 · Johnson & Johnson: 21.38 B USDQ1 24 · Pfizer: 14.88 B USDQ1 24Q2 24 · Johnson & Johnson: 22.45 B USDQ2 24 · Pfizer: 13.28 B USDQ3 24 · Johnson & Johnson: 22.47 B USDQ3 24 · Pfizer: 17.70 B USDQ4 24 · Johnson & Johnson: 22.52 B USDQ4 24Q1 25 · Johnson & Johnson: 21.89 B USDQ1 25 · Pfizer: 13.72 B USDQ2 25 · Johnson & Johnson: 23.74 B USDQ2 25 · Pfizer: 14.65 B USDQ3 25 · Johnson & Johnson: 23.99 B USDQ3 25 · Pfizer: 16.65 B USDQ3 25Q4 25 · Johnson & Johnson: 24.56 B USDQ4 25 · Pfizer: 17.56 B USDQ1 26 · Johnson & Johnson: 24.06 B USDQ1 26 · Pfizer: 14.45 B USDQ2 26 · Johnson & Johnson: 25.31 B USDQ2 26 · Pfizer: 15.03 B USDQ2 26USD

Net income

Johnson & JohnsonPfizer
05B10BQ3 22 · Johnson & Johnson: 4.81 B USDQ3 22 · Pfizer: 9.91 B USDQ3 22Q4 22 · Johnson & Johnson: 4.46 B USDQ4 22 · Pfizer: 4.99 B USDQ1 23 · Johnson & Johnson: 3.52 B USDQ2 23 · Johnson & Johnson: -68.00 M USDQ2 23 · Pfizer: 5.54 B USDQ2 23Q3 23 · Johnson & Johnson: 5.14 B USDQ3 23 · Pfizer: 2.33 B USDQ4 23 · Johnson & Johnson: 4.05 B USDQ4 23 · Pfizer: -3.37 B USDQ1 24 · Johnson & Johnson: 3.26 B USDQ1 24 · Pfizer: 3.12 B USDQ1 24Q2 24 · Johnson & Johnson: 4.69 B USDQ2 24 · Pfizer: 41.00 M USDQ3 24 · Johnson & Johnson: 2.69 B USDQ3 24 · Pfizer: 4.47 B USDQ4 24 · Johnson & Johnson: 3.43 B USDQ4 24Q1 25 · Johnson & Johnson: 11.00 B USDQ1 25 · Pfizer: 2.97 B USDQ2 25 · Johnson & Johnson: 5.54 B USDQ2 25 · Pfizer: 2.91 B USDQ3 25 · Johnson & Johnson: 5.15 B USDQ3 25 · Pfizer: 3.54 B USDQ3 25Q4 25 · Johnson & Johnson: 5.12 B USDQ4 25 · Pfizer: -1.65 B USDQ1 26 · Johnson & Johnson: 5.24 B USDQ1 26 · Pfizer: 2.69 B USDQ2 26 · Johnson & Johnson: 5.53 B USDQ2 26 · Pfizer: -248.00 M USDQ2 26USD

Free cash flow

Johnson & JohnsonPfizer
05BQ3 22 · Johnson & Johnson: 4.72 B USDQ3 22 · Pfizer: 7.42 B USDQ3 22Q4 22 · Johnson & Johnson: 5.33 B USDQ4 22 · Pfizer: 7.58 B USDQ1 23 · Johnson & Johnson: 3.76 B USDQ2 23 · Johnson & Johnson: 2.39 B USDQ2 23 · Pfizer: 73.00 M USDQ2 23Q3 23 · Johnson & Johnson: 3.06 B USDQ3 23 · Pfizer: -2.12 B USDQ4 23 · Johnson & Johnson: 6.27 B USDQ4 23 · Pfizer: 4.20 B USDQ1 24 · Johnson & Johnson: 2.85 B USDQ1 24 · Pfizer: 386.00 M USDQ1 24Q2 24 · Johnson & Johnson: 4.66 B USDQ2 24 · Pfizer: -2.42 B USDQ3 24 · Johnson & Johnson: 6.96 B USDQ3 24 · Pfizer: 6.06 B USDQ4 24 · Johnson & Johnson: 5.37 B USDQ4 24Q1 25 · Johnson & Johnson: 3.38 B USDQ1 25 · Pfizer: 1.77 B USDQ2 25 · Johnson & Johnson: 2.48 B USDQ2 25 · Pfizer: -1.20 B USDQ3 25 · Johnson & Johnson: 8.00 B USDQ3 25 · Pfizer: 4.00 B USDQ3 25Q4 25 · Johnson & Johnson: 5.47 B USDQ4 25 · Pfizer: 4.50 B USDQ1 26 · Johnson & Johnson: 1.47 B USDQ1 26 · Pfizer: 2.18 B USDQ2 26 · Johnson & Johnson: 7.30 B USDQ2 26 · Pfizer: 302.00 M USDQ2 26USD

EPS

Johnson & JohnsonPfizer
024Q3 22 · Johnson & Johnson: 1.80Q3 22 · Pfizer: 1.73Q3 22Q4 22 · Johnson & Johnson: 1.68Q4 22 · Pfizer: 0.86Q1 23 · Johnson & Johnson: 1.33Q2 23 · Johnson & Johnson: -0.03Q2 23 · Pfizer: 0.97Q2 23Q3 23 · Johnson & Johnson: 1.96Q3 23 · Pfizer: 0.41Q4 23 · Johnson & Johnson: 1.67Q4 23 · Pfizer: -0.59Q1 24 · Johnson & Johnson: 1.34Q1 24 · Pfizer: 0.55Q1 24Q2 24 · Johnson & Johnson: 1.93Q2 24 · Pfizer: 0.01Q3 24 · Johnson & Johnson: 1.11Q3 24 · Pfizer: 0.78Q4 24 · Johnson & Johnson: 1.41Q4 24Q1 25 · Johnson & Johnson: 4.54Q1 25 · Pfizer: 0.52Q2 25 · Johnson & Johnson: 2.29Q2 25 · Pfizer: 0.51Q3 25 · Johnson & Johnson: 2.12Q3 25 · Pfizer: 0.62Q3 25Q4 25 · Johnson & Johnson: 2.10Q4 25 · Pfizer: -0.29Q1 26 · Johnson & Johnson: 2.14Q1 26 · Pfizer: 0.47Q2 26 · Johnson & Johnson: 2.27Q2 26 · Pfizer: -0.04Q2 26

EBITDA

Johnson & JohnsonPfizer
05B10B15BQ3 22 · Johnson & Johnson: 7.62 B USDQ3 22Q4 22 · Johnson & Johnson: 7.06 B USDQ4 22 · Pfizer: 7.06 B USDQ1 23 · Johnson & Johnson: 6.08 B USDQ2 23 · Johnson & Johnson: 1.23 B USDQ2 23 · Pfizer: 8.06 B USDQ2 23Q3 23 · Johnson & Johnson: 8.35 B USDQ3 23 · Pfizer: 4.34 B USDQ4 23 · Johnson & Johnson: 6.74 B USDQ4 23 · Pfizer: -1.81 B USDQ1 24 · Johnson & Johnson: 5.68 B USDQ1 24 · Pfizer: 5.93 B USDQ1 24Q2 24 · Johnson & Johnson: 7.80 B USDQ2 24 · Pfizer: 2.42 B USDQ3 24 · Johnson & Johnson: 5.38 B USDQ3 24 · Pfizer: 7.24 B USDQ4 24 · Johnson & Johnson: 5.92 B USDQ4 24Q1 25 · Johnson & Johnson: 15.61 B USDQ1 25 · Pfizer: 5.05 B USDQ2 25 · Johnson & Johnson: 8.74 B USDQ2 25 · Pfizer: 5.32 B USDQ3 25 · Johnson & Johnson: 9.52 B USDQ3 25 · Pfizer: 5.65 B USDQ3 25Q4 25 · Johnson & Johnson: 7.19 B USDQ4 25 · Pfizer: 756.00 M USDQ1 26 · Johnson & Johnson: 8.27 B USDQ1 26 · Pfizer: 5.45 B USDQ2 26 · Johnson & Johnson: 8.99 B USDQ2 26 · Pfizer: 1.64 B USDQ2 26USD

Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.

Change the comparison

vs

Type each company's ticker (AAPL, MSFT, SAN.MC…). Suggestions cover the companies we track, but any Yahoo Finance symbol works.

Other comparisons

Apple vs MicrosoftMicrosoft vs Alphabet (Google)Alphabet (Google) vs Meta PlatformsNvidia vs AMDAMD vs IntelNvidia vs TSMCTSMC vs IntelASML vs TSMCBroadcom vs QualcommMicron vs Texas InstrumentsCoca-Cola vs PepsiCoVisa vs MastercardAmazon vs WalmartWalmart vs CostcoTesla vs ToyotaFord vs General MotorsRivian vs LucidExxonMobil vs ChevronAT&T vs VerizonEli Lilly vs Novo NordiskUnitedHealth vs Johnson & JohnsonNetflix vs Walt DisneySpotify vs NetflixUber vs Airbnb